Risk-Based Monitoring – Industry update, guidance and reflections
What is risk-based monitoring (RBM)? What benefits can we see using RBM in clinical studies?
We welcome you all to what will be an exciting, open and interactive seminar. Ed Tumaian, VP Clinical Development at TFS, will give an update on the situation in the market place, taking regulatory guidelines into consideration and share his many years of experience working with implementation and execution of RBM in global clinical studies.
For more than 25 years Ed has been working in the life-sciences and healthcare industries, building and leading teams in clinical operations as well as portfolio and partnership management. He has extensive experience in global management across regions and countries, most recently as Sr. Director Project Leadership at QuintilesIMS leading a large RBM portfolio.
Lunch & Learn occurs first Tuesday each month and is open for everyone to attend - no registration needed. The event is hosted by a Medicon Village member organization or an industry network organization. Participants buys their lunch in the restaurant and we all gather in the lower section. Take the opportunity to learn something new and useful in your work life.